Research Round Up Podcast: Gynecologic Cancer

Research Round Up Podcast Series
September 13, 2016
Claire Smith, ASCO staff

Scientists’ understanding of ovarian, fallopian tube, and peritoneal cancer is rapidly changing. share on twitter  Fallopian tube cancer was previously thought to be a rare type of cancer, but now scientists understand that ovarian, fallopian tube, and peritoneal cancer are all closely linked. As Cancer.Net Associate Editor Jonathan Berek, MD, MMS, explains in this Research Round Up podcast, “Recently, we have determined that most ovarian cancer arises in the fallopian tube.” 

Dr. Berek also discusses the following studies from the 2016 ASCO Annual Meeting:

  • A study on the oral drug, olaparib (Lynparza), a type of targeted therapy known as a PARP inhibitor, given as a maintenance therapy after chemotherapy. Maintenance therapy is the treatment of cancer with medication, typically following an initial round of treatment [2:24].

  • Two studies compared intraperitoneal (IP) chemotherapy, which is chemotherapy given directly into the abdomen, to intravenous (IV) chemotherapy, which is chemotherapy given directly into a blood vessel [4:53].

  • A large UK-based study of screening options for early detection of ovarian cancer [6:54].

  • A large study that looked at quality of life for women with recurrent ovarian cancer and whether certain quality-of-life indicators could help predict longer life [8:24].

  • Two studies that explored treatment options for metastatic endometrial cancer and low-grade serous carcinoma of the ovary [9:50].

This is a prerecorded audio podcast. It can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.